0001209191-20-024164.txt : 20200410
0001209191-20-024164.hdr.sgml : 20200410
20200410182529
ACCESSION NUMBER: 0001209191-20-024164
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200331
FILED AS OF DATE: 20200410
DATE AS OF CHANGE: 20200410
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Suri Anish
CENTRAL INDEX KEY: 0001739130
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38327
FILM NUMBER: 20787615
MAIL ADDRESS:
STREET 1: 21 ERIE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cue Biopharma, Inc.
CENTRAL INDEX KEY: 0001645460
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473324577
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21 ERIE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-949-2680
MAIL ADDRESS:
STREET 1: 21 ERIE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Imagen Biopharma, Inc.
DATE OF NAME CHANGE: 20150617
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-03-31
0
0001645460
Cue Biopharma, Inc.
CUE
0001739130
Suri Anish
C/O CUE BIOPHARMA, INC.
21 ERIE STREET
CAMBRIDGE
MA
02139
0
1
0
0
President and CSO
Common Stock
2020-03-31
4
M
0
16666
0.00
A
39912
D
Common Stock
2020-03-31
4
F
0
5354
0.00
D
34558
D
Restricted Stock Units
2020-03-31
4
A
0
50000
0.00
A
Common Stock
50000
116667
D
Restricted Stock Units
2020-03-31
4
M
0
16666
0.00
D
Common Stock
16666
100001
D
Each restricted stock unit represents a contingent right to receive one share of common stock.
Represents an award of restricted stock units granted on March 31, 2020 pursuant to the reporting person's employment agreement. The restricted stock units vest in three equal annual installments beginning on March 31, 2020.
/s/ Anish Suri by Mark Busch, attorney-in-fact
2020-04-10